Navigation Links
Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th
Date:6/3/2008

Company's DSU Products offer biologically safe water through point-of-use

ultrafiltration

NEW YORK, June 3 /PRNewswire-FirstCall/ -- Nephros, Inc., a medical device company, announced today that it will be exhibiting its Dual Stage Ultrafilter products at the Association for Professionals in Infection Control and Epidemiology (APIC) conference in Denver, Colorado, June 15th-19th, 2008. Building on the success of the Nephros online hemodiafiltration technology, the Nephros Dual Stage Ultrafilter (DSU) delivers water free of bacteria, viruses, fungi, and other biologically hazardous elements. The Company believes the DSU can be an important addition to the hospital's arsenal in addressing water-borne hospital acquired infection (HAI) risks, and therefore help to reduce infection-related hospital costs and liability associated with prolonged hospital stays, additional care requirements, and patient mortality.

HAIs of all types are a significant problem in the U.S. According to the Centers for Disease Control and Prevention (CDC), there are over 2 million HAIs annually in the U.S., resulting in an estimated $30.5 billion in additional healthcare costs and over 100,000 in-hospital deaths. The federal Medicare program recently announced that, beginning in October 2008, it will no longer pay extra costs associated with certain types of HAIs. A variety of pathogens survives and even thrives in hospital plumbing systems despite chemical and heat-based treatments designed to eradicate them. Waterborne microbes can shelter certain pathogens and transport them to locations throughout a hospital's water system.

"Our Dual Stage Ultrafilter is designed with a fail-safe feature, offering biologically pure water with extremely high reliability. "We believe that, when addressing water-borne HAIs, hospitals will seek a product that both has the biological stopping power to protect patients, and is convenient and cost-effective.
'/>"/>

SOURCE Nephros, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Nephros Strengthens Commercialization Team with Addition of Marketing Executive
2. Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008
3. Nephros Reports 2008 First Quarter Financial Results
4. Announcing Always Best Care Senior Services Expansion Into the Littleton/Denver, Colorado Area
5. CRH Medical Corporation opens new center in Denver, Colorado
6. Latest Advances in Infection Prevention and Control to be Presented in Denver, CO at Worlds Largest Annual Infection Prevention Conference, June 15-19, 2008
7. Colorado Medical School Receives Provisional Accreditation
8. Partnership for a Drug-Free America and Colorado Springs Police Department Introduce Methamphetamine Prevention Program to Colorado Law Enforcement
9. Angel Flight West Recognizes Colorado Pilots and Supporters at AFW 24th Anniversary Awards
10. Colorado Doctors of Chiropractic Win Awards
11. Golden Doctor of Chiropractic Elected President of the Colorado Chiropractic Association

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...ssing someone get blamed for something leads to mo... , SUNDAY, Nov. 29 (HealthDay News) -- The...ts, even when the target is innocent. , Researc...one else for a problem, even if it,s an unfair acc...ming others, too. , "When we see others protec...
(Date:11/28/2009)... , CHICAGO, Nov. 28 Welcome...CS solution for the clinical routine from Siemen...nd Communications System (PACS) from Siemens whe...ce, syngo .plaza is poised to change the way ...veiling this innovation at the 95th Scientific A...
(Date:11/27/2009)... , BEDFORD, Mass., Nov. 27 /PRNewswire-FirstC...ompany"), a supplier of precision technology produ...t an annual meeting of the Company,s shareholders ...e time and location of the meeting will be announc...mpany received a requisition notice from Stephen B...
(Date:11/27/2009)... , ROCHESTER, N.Y., Nov. 27 /PRNewswire-USNews...ealth care provider and fortunately every year, ne...evention. But do all vaccines boost immunity for t...tional ,booster shots, needed to keep immunity str...the Journal of the American Academy of Pediatrics,...
(Date:11/27/2009)...ng rates to bring unprecedented medical, economic ... 27 (HealthDay News) -- The number of people with ...e over the next 25 years, a new study predicts. ,...1 million people with the disease, up from 23.7 mi...reating people with diabetes will triple, the stud...
Breaking Medicine News(10 mins):Health News:When Accusations Start to Fly, They Multiply 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
...f Millions In Rebates to Medicaid Program , , WAS...ave joined in two whistleblower suits filed in the...cturer, Wyeth, alleging that the company knowingly...As a result, Wyeth allegedly avoided paying hundre...
... and cell biologists have identified a new molecul...tate cancers. , In a preclinical study led by M...aneous inactivation of two particular genesknown ...enes could result in benign tumors, but when those...
...ay help some , , MONDAY, May 18 (HealthDay...he other an appliance that adjusts the jaw -- migh...ough to treat. , In sleep apnea, the upper airway ...ally treated with a device that increases air pres...
... APD ) today announced it has sold three of its ...n, Inc. (LMI), the largest provider of durable med...in the northeast, based in Mount Vernon, N.Y. Ter... the Air Products Healthcare LLC Group, namely Gen...
...May 13, 2009, as Minnesota became the first state ...alth provider into state statute - enabling studen...ene Practitioner (ADHP) model to become licensed t... Therapist providers in the state. Minnesota Gover...
...006 , , DETROIT, May 18 A just-completed financi...the Michigan Office of Financial and Insurance Reg...ancial statements over the audit,s four-year perio... by the National Association of Insurance Commissi...
Other Medicine News:Health News:U.S. and 16 States Join Suits Against Pharmaceutical Giant, Wyeth 2Health News:U.S. and 16 States Join Suits Against Pharmaceutical Giant, Wyeth 3Health News:Research reveals molecular pathway behind invasive prostate cancers 2Health News:New Options Offered for Sleep Apnea 2Health News:New Options Offered for Sleep Apnea 3Health News:New Options Offered for Sleep Apnea 4Health News:Air Products Sells Three U.S. Healthcare Businesses to Landauer-Metropolitan 2Health News:Minnesota Passes Legislation Allowing Mid-level Oral Health Provider 2Health News:Minnesota Passes Legislation Allowing Mid-level Oral Health Provider 3Health News:State Audit of Blue Cross Blue Shield of Michigan Shows Company in Compliance with State and National Accounting Guidelines 2
(Date:11/27/2009)..., SALT LAKE CITY, Nov. 27 /PRNewswire-FirstCall/...tems, Inc. (NYSE: VAR ), a premier supplier of X... will exhibit its full range of detectors at the R...29 - December 3, 2009. Varian will also be exhibi... as well as specialized cancer treatment technolog...
(Date:11/27/2009)..., CHICAGO, Nov. 27 At the upcom...nnual meeting starting Sunday, Royal Philips Elect...ge of healthcare imaging and informatics solutions...tients and care providers, by delivering meaningfu...lue, modular price points and easy upgradability. ...
(Date:11/25/2009)..., CANOGA PARK, Calif., Nov. 25 Pr...ce rankings in the American Academy of Family Phys...09 EHR User Satisfaction Survey for improving medi...ement, all critical for new ARRA Stimulus legislat...g their EMR had a positive effect in determining t...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2USHairReplacement com Provides Wealth of Knowledge to Common Hair Replacement Questions 48877 1USHairReplacement com Provides Wealth of Knowledge to Common Hair Replacement Questions 48877 2High Activity Plant Based Diamine Oxidase Enzyme Introduced by Bio Research Products 48873 1While the Dangers of Sun Exposure are Widely Understood Americans Fall Short of Adequately Protecting Themselves from the Sun 48869 1While the Dangers of Sun Exposure are Widely Understood Americans Fall Short of Adequately Protecting Themselves from the Sun 48869 2While the Dangers of Sun Exposure are Widely Understood Americans Fall Short of Adequately Protecting Themselves from the Sun 48869 3While the Dangers of Sun Exposure are Widely Understood Americans Fall Short of Adequately Protecting Themselves from the Sun 48869 4
...BUSINESS WIRE)--Apr 14, 2007 - In a late-breaker,p...pean Association,for the Study of the Liver (EASL)...interim analysis of the PROVE 1 clinical trial,wh...therapy with,the investigational hepatitis C prote...ion with pegylated interferon (peg-IFN) and,ribavi...
...SS WIRE)--Apr 16, 2007 - Antigenics Inc.,(NASDAQ: ...ted data,from a Phase 1/2 investigator-sponsored t...ne Oncophage(R) (vitespen) in,recurrent, high-grad...n Association of Neurological Surgeons (AANS; abst...ing conducted at the,Brain Tumor Research Center a...
Other Medicine Technology:Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 2Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 4Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 6Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 7Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 8Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 2Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 3Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 4
... come with five legs for extra stability. Adjustab...el 6"). 2" ball bearing swivel hard rubber castors...ry, available in black vinyl as standard, other co...red, padded, upholstered backrest, with vertical a...
Lacrimal Cannula, 19 g / 23 g. Straight
Anterior Chamber Needle, 21 g
Nucleus Hydrodissection Cannula, 25 g
Medicine Products: